Literature DB >> 28288200

Morphological features of the left atrial appendage in consecutive coronary computed tomography angiography patients with and without atrial fibrillation.

Miika Korhonen1,2, Johannes Parkkonen1,2, Marja Hedman3, Antti Muuronen1,2, Juha Onatsu4, Pirjo Mustonen5, Ritva Vanninen1,2, Mikko Taina1,2.   

Abstract

The majority of intracardiac thrombi form in the left atrial appendage (LAA). Enlargement of this structure, together with certain morphological features, may indicate a predisposition to the formation of thrombi and subsequent cardioembolic stroke. Thus far, studies on LAA morphology have largely focused on those patients with atrial fibrillation (AF). Taking a different approach, we investigated the variation in LAA morphology in a consecutive patient population with and without AF. We evaluated 808 consecutive patients (529 females; mean age 52.5±9.9 years) who underwent coronary artery computed tomography angiography (CCTA), the majority of whom (749) had no history of AF. We assessed the length, lobe number, and morphological classification of their LAAs. Demographic data and medical histories were collated from medical records and then correlated with LAA morphology. The proportions of each of the four morphological classes of LAA for the overall vs. non-AF population were: WindSock, 62.3/61.5%; Cactus, 18.6/18.8%; ChickenWing, 10.0/10.0%; and CauliFlower, 9.2/9.6%. Age (p<0.001; r = 0.156) and female gender (p<0.001) were both found to be associated with an increased body surface area (BSA)-related LAA length. Male patients were more likely to manifest multi-lobed (p = 0.003) LAAs, and overweight patients with a greater number of multi-lobed LAA morphological classes (p = 0.010). No associations with morphological LAA features could be found for patients with diabetes, hypertension, or dyslipidemia. Nor did the size of the left atrium exhibit any correlation with BSA-related LAA length. In the overall and non-AF populations, aging and female gender were associated with longer BSA-indexed LAAs.

Entities:  

Mesh:

Year:  2017        PMID: 28288200      PMCID: PMC5348027          DOI: 10.1371/journal.pone.0173703

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Approximately one in every four cases of ischemic stroke has an underlying cardioembolic mechanism [1]. This fraction may even be an underestimate given that this etiology remains cryptogenic in approximately 25% of all cases [2]. In 90% of cardiogenic strokes, the left atrial appendage (LAA) serves as the site for thrombus formation, prompting extensive medical research into this relatively small structure [3,4]. The most common cause of cardioembolism is atrial fibrillation (AF) [5]. With time, AF alters not only the hemodynamics within the heart, but also simultaneously remodels the left atrium (LA), especially the LAA [6]. Earlier studies have revealed that certain LAA morphologies may be over-represented in patients with cardioembolic stroke [7-9]. The identification of LAA features that might predispose to AF could serve as a useful predictive tool with which to identify patients at an increased risk for paroxysmal AF and, ultimately, life-threatening cardiogenic stroke. Previous studies on LAA morphology have primarily focused on patients with AF [7-9]. Besides AF, various medical conditions such as coronary artery disease (CAD), valvular diseases, together with age, gender, and obesity, might influence LAA morphology [10-14]. Examining these potential remodeling factors in the absence of AF as a complicating factor would be of considerable value in the design of a predictive screening tool. The aim of this work was to analyze LAA morphology in patients of different age, gender, and with diverse diagnoses of medical condition. We investigated a large population comprising consecutive patients who had undergone coronary artery computed tomography angiography (CCTA), the majority with no history of AF.

Materials and methods

All clinical investigations were conducted according to the principles of the Declaration of Helsinki. The Kuopio University Hospital Research Ethics Board approved this study (N:o 82/2004). The Chair of the Hospital District waived the need for written informed consent for these retrospective analyses.

Study population

The study population comprised consecutive patients admitted to Kuopio University Hospital for CCTA between October 2009 and July 2015. The main indications for imaging were to rule out CAD in patients with a low to moderate pretest probability, to screen for heart failure etiology, or to identify coronary anomalies. This study also included young patients undergoing a preoperative evaluation prior to cardiac valve surgery due to mitral or aortic valve regurgitation, but excluding aortic stenosis. Altogether, 816 patients were imaged. Excluded patients included 3 who were less than 18 years of age, 3 because their LAA could not be reliably assessed from the CCTA image, and 2 patients who suffered AF during CCTA.

Computed tomography angiography of the coronary arteries

CTA imaging of the coronary arteries was performed in mid-diastole (tube voltage 80–120 mV, 330 mAs) with 64-, 128- slice, and dual energy scanners (Somatom Definition AS 64; Somatom Definition AS+ 128; Definition Edge; Definition Flash, Siemens Medical Solutions, Forchheim, Germany). Collimation was 64x0.6 mm for the Somatom Definition AS 64, and 128x0.6 mm for all other scanners. Following scout acquisition to ensure the precise timing of contrast injection, a test bolus of 10 ml contrast was discharged and measured 5 mm superior to the origin of the left main coronary artery with dual energy scanners; bolus tracking was used for the other scanners. The volume of the contrast agent (Omnipaque 350 mg/ml, GE Healthcare) was 50–80 ml, delivered at an injection rate of 5 ml/s, followed by a 30 mL saline chaser. To achieve a target heart rate of <65 beats per minute, patients with higher initial heart rates were administered 5–20 mg of intravenous metoprolol prior to their examination. Imaging was performed in mid-diastole during sinus rhythm apart from in two patients who suffered from persistent AF. Prospective ECG gating provided helical scan data. Images were reconstructed immediately after scanning; electrocardiographically gated datasets were routinely reconstructed at the 75% phase in the cardiac cycle and, in case of helical scanning, 200–400 ms after the R wave. Our imaging protocol adhered to conventional clinical procedures. The mean effective radiation dose (mSv) during CCTA in the study population was estimated using the conversion factor of 0.028 [15].

Data assessment

CCTA images were retrospectively analyzed visually and quantitatively with respect to the length, number of lobes, and morphological classification of the LAA by an experienced observer (MK) using an IDS7 diagnostic workstation (version 17.3.6; Sectra Imtec, Linköping, Sweden). A multiplanar reconstruction provided a three-dimensional perspective. LAA length was measured from the center of the orifice to the most distant point of the LAA, via the center of the main lobe. The LAA bend angle was measured between the axis of the main lobe and the possible secondary lobe (Fig 1). Based on the number of lobes, LAAs were initially classified as one-, two-, or multi-lobed structures. This was followed by a morphological categorization into one of four classes: WindSock, ChickenWing, CauliFlower, or Cactus (Fig 1), as based on the criteria previously described by Wang et al. [16], and Kimura et al. [8].
Fig 1

Morphological categories of the Left Atrial Appendage (LAA), as based on Wang’s classification with Kimura’s quantitative qualifiers.

The dashed line at the LAA orifice represents the base line from which quantitative measurements were made. The blue line indicates how LAA length and bend angle were derived. Differences between the ChickenWing (<100-degrees) and WindSock category (>100-degrees) are also based on the angle at the proximal part of the LAA.

Morphological categories of the Left Atrial Appendage (LAA), as based on Wang’s classification with Kimura’s quantitative qualifiers.

The dashed line at the LAA orifice represents the base line from which quantitative measurements were made. The blue line indicates how LAA length and bend angle were derived. Differences between the ChickenWing (<100-degrees) and WindSock category (>100-degrees) are also based on the angle at the proximal part of the LAA. Demographic information, medical histories, and lifestyle factors were also collated from medical records. The patient was considered to be overweight if this status was either explicitly reported in their medical record, or if their Body Mass Index (BMI), if available, exceeded 25; obesity was defined as a BMI of over 30. Body surface area (BSA) was calculated using Mosteller’s formula [17]. Thereafter, to minimize the influences of body mass and height on LAA length and LA area, relative values were derived by dividing measurements for LAA length and LA area by BSA values. Diabetes was not classified into subtype. Patients who continuously smoked, or had ceased smoking less than 30 years ago, were considered smokers. The degree of atherosclerosis in coronary arteries was estimated from CCTA analyses performed by experienced radiologists or cardiologists. Non-calcified arteries bore no sign of atherosclerosis whereas stenosis of over 50% was considered significant. LA areas were non-routinely measured from an optimized three-chamber view at the mid-diastolic phase. The severity of valvular regurgitation was classified as either mild, moderate, moderately severe, or severe, based on echocardiography reports. Both moderately severe and severe valvular disease were considered to be of hemodynamic significance and were therefore included in our analyses.

Statistical analyses

To assess the relationships between age and LAA morphology, the study population was subdivided based on median age, age-related quartiles, or the following age categories: <40 years, 40–49 years, 50–59 years, or ≥60 years. Continuous variables are presented as mean ±SD, with categorical variables shown as absolute values and percentages. Statistical significance was set at p<0.05, with high significance set at p<0.001. Spearman’s correlation coefficient was used to investigate the associations between continuous variables, with the Chi-Square test applied to investigate nominal variables. Based on the outcome of the Kolmogorov-Smirnov test, either the Student’s t-test or Mann Whitney U test, were used to compare dichotomized groups for normally distributed or abnormally distributed variables, respectively. The Kruskal-Wallis test was used to analyze continuous variables between multiple groups, with linear regression analyses used to calculate the effects of background factors on relative LAA length and relative LA area as a dependent continuous variable. Data were analyzed using SPSS for Mac (version 22, 1989–2013 SPSS Inc., Chicago, USA).

Results

Overall study group

The original study group comprised 808 patients (mean age 52.5 years, 529 women). The majority (n = 749) of these patients had no history of AF. Patients with AF were older, more frequently male, and were more likely to have a history of stroke, TIA, and significant valvular disease. Details of characteristics with comparisons between the AF and non-AF patients are shown in Table 1. The mean effective radiation dose during CCTA was 6.3 mSv.
Table 1

Clinical characteristics of the study group.

CharacteristicAll patients (N = 808)Non-AF patients (N = 749)AF patients (N = 59)P value a
ValueAnalyzed, NValueAnalyzed, NValueAnalyzed, N
Age, years52.5±9.980852.3±9.874955.0±11.0590.032
Females (%)529 (65.5)808498 (66.5)74831 (52.5)590.030
Overweight (BMI>25)419 (61.4)682383 (60.8)63036 (69.2)52ns
Obese (BMI>30)163 (31.0)525150 (31.3)47913 (28.3)46ns
Body surface area, m21.93±0.255271.92±0.254811.99±0.19460.043
Caucasian807 (100)808748 (100)74959 (100)59ns
Hypertension409 (50.6)808374 (49.9)74935 (59.3)59ns
Dyslipidemia488 (64.7)754447 (63.9)70041 (75.9)54ns
Diabetes42 (5.7)74039 (5.7)6903 (6.0)50ns
Smokers251 (33.8)743231 (33.6)68820 (36.4)55ns
Sinus rhythm700 (86.6)808
Atrial flutter5 (0.6)808
Paroxysmal AF58 (7.2)808
Chronic AF1 (0.1)808
Non-calcified and non-stenotic coronary arteries450 (55.7)808423 (56.5)74927 (45.8)59ns
Over 50% stenosis in coronary arteries142 (17.6)808128 (17.1)74914 (23.7)59ns
Prior myocardial infarction11 (1.4)80811 (1.5)7490 (0)59ns
Prior stroke or TIA39 (4.8)80631 (4.1)7478 (13.6)590.001
Moderately severe or severe mitral regurgitation6 (0.7)8085 (0.7)7491 (1.7)59ns
Moderately severe or severe aortic regurgitation16 (2.0)80812 (1.6)7494 (6.8)590.006
LA area, cm218.8±5.720418.1±5.118124.2±7.623<0.001
Heart failure12 (1.5)80811 (1.5)7491 (1.7)59ns

AF, Atrial Fibrillation; BMI, Body Mass Index; LA, Left Atrium; ns, not significant; TIA, Transient Ischemic Attack.

a Statistical significance between AF patients and non-AF patients.

AF, Atrial Fibrillation; BMI, Body Mass Index; LA, Left Atrium; ns, not significant; TIA, Transient Ischemic Attack. a Statistical significance between AF patients and non-AF patients. The prevalence of LAA morphological classes and their relative LAA lengths were analyzed according to the classification criteria detailed in Tables 2 and 3, and illustrated in Figs 2 and 3. Gender (2.26±0.48 cm/m2 in female vs. 2.09±0.48 cm/m2 in male; p<0.001) and smoking (2.13±0.48 cm/m2 vs. 2.24±0.49 cm/m2; p = 0.041) were both significantly associated with relative LAA length, although men were more likely to be smokers than women (46.9% vs. 26.8%; p<0.001). As shown in Table 4, a higher age was associated with longer relative LAA lengths (r = 0.156; p<0.001), and larger relative LA areas (r = 0.861; p<001). Fig 4 illustrates the differences in relative LAA length and area according to age quartile.
Table 2

Associations between the morphological features of the left atrial appendage, the left atrium area, demographic data, and medical histories for the overall study population (n = 808).

CharacteristicN, positives or mean±SD (N, total)LAA morpho-logical class (P)LAA lobes (P)LAA length (P)Relative LAA lengthLA areaRelative LA area
N, positives or mean±SD (N, total)PN, positives or mean±SD (N, total)PN, positives or mean±SD (N, totalP
Females529 (808)ns0.007<0.001349 (527)<0.001124 (204)<0.00174 (124)ns
Overweight (BMI>25)419 (682)<0.001nsnsNANA93 (166)<0.001NANA
Obese (BMI>30)163 (525)nsnsnsNANA38 (122)0.004NANA
Body surface area, m21.93±0.25 (527)0.004ns<0.001NANA1.96±0.25 (124)<0.001NANA
Hypertension409 (808)nsnsns289 (527)ns99 (204)0.00267 (124)ns
Dyslipidemia488 (754)nsnsns337 (498)ns106 (189)ns68 (114)0.043
Diabetes42 (740)nsnsns38 (487)ns11 (184)ns10 (112)ns
Smokers251 (743)nsnsns174 (492)0.04150 (185)ns34 (115)ns
Atrial fibrillation59 (808)nsns0.03346 (527)ns23 (204)<0.00117 (124)0.004
Non-calcified and non-stenotic coronary arteries450 (808)nsns0.031269 (527)ns123 (204)0.03566 (124)0.045
Over 50% stenosis in coronary arteries142 (808)nsnsns101 (527)ns25 (204)0.03719 (124)ns
Prior myocardial infarction11 (808)nsnsns11 (527)ns6 (204)0.0096 (124)0.015
Prior stroke or TIA39 (806)nsnsns39 (526)ns9 (204)ns8 (124)ns
Moderately severe or severe mitral regurgitation6 (808)nsnsns5 (527)ns3 (204)0.0262 (124)0.045
Moderately severe or severe aortic regurgitation16 (808)nsns0.0108 (525)ns6 (201)ns3 (122)0.008
LA area, cm218.8±5.7 (204)nsns<0.00119.2±5.6 (124)nsNANANANA
Heart failure12 (808)nsns0.0438 (527)ns4 (204)0.0102 (124)ns

BMI, Body Mass Index; LA, Left Atrium; LAA, Left Atrial Appendage; NA, not applicable; ns, not significant; TIA, Transient Ischemic Attack.

Table 3

Associations between morphological features of the left atrial appendage, the left atrium area, demographic information, and the medical histories of patients without persistent or paroxysmal atrial fibrillation (n = 749).

CharacteristicN, positives or mean±SD (N, total)LAA morpho-logical class (P)LAA lobes (P)LAA length (P)Relative LAA lengthLA areaRelative LA area
N, positives or mean±SD (N, total)PN, positives or mean±SD (N, total)PN, positives or mean±SD (N, total)P
Females498 (749)ns0.015<0.001326 (481)<0.001112 (181)0.00266 (107)ns
Overweight (BMI>25)383 (630)0.003nsnsNANA79 (147)<0.001NANA
Obese (BMI>30)150 (479)nsnsnsNANA31 (105)0.001NANA
Body surface area, m21.92±0.25 (481)0.018ns<0.001NANA1.95±0.25 (106)<0.001NANA
Hypertension374 (749)nsnsns260 (481)ns84 (181)0.00357 (107)ns
Dyslipidemia447 (700)nsnsns305 (456)ns90 (169)ns57 (107)ns
Diabetes39 (690)nsnsns35 (448)ns11 (165)ns10 (99)ns
Smokers231 (688)nsnsns158 (449)0.03943 (165)ns28 (100)ns
Non-calcified and non-stenotic coronary arteries423 (749)nsns0.031251 (481)ns113 (181)ns61 (107)ns
Over 50% stenosis in coronary arteries128 (749)nsnsns89 (481)ns20 (181)ns14 (107)ns
Prior myocardial infarction11 (749)nsnsns11 (481)ns6 (181)0.0056 (107)0.009
Prior stroke or TIA31 (747)nsnsns22 (480)ns8 (181)ns7 (107)ns
Moderately severe or severe mitral regurgitation5 (749)nsnsns4 (481)ns3 (181)0.0152 (107)0.034
Moderately severe or severe aortic regurgitation12 (749)nsns0.0184 (479)ns3 (178)ns0 (105)NA
LA area18.1±5.1 (181)nsns0.00118.57±5.3 (107)nsNANANANA
Heart failure11 (749)nsnsns7 (481)ns4 (181)0.0062 (107)ns

BMI, Body Mass Index; LA, Left Atrium; LAA, Left Atrial Appendage; NA, not applicable; ns, not significant; TIA, Transient Ischemic Attack.

Fig 2

Correlates between morphological classes of the left atrial appendage and classification criteria.

Fig 3

Correlates between relative left atrial appendage length and classification criteria.

Table 4

Correlates between features of the left atrial appendage and age classifications.

NLAA classes (P)LAA lobes (P)LAA length (P)Relative LAA lengthLA areaRelative LA area
NPNPNP
Age as a continuous variable808nsnsns527<0.001 a2040.034 b124<0.001 c
    Non-AF patients749nsnsns481<0.001 d181ns107<0.001 e
    AF patients59nsnsns46ns23ns17<0.001 f
Over 53 years g399nsnsns2660.00491ns1240.004
    Non-AF patients362nsnsns2370.00978ns1070.006
    AF patients37nsnsns29ns13ns17ns
Quartiles according to age h808nsnsns5270.002204ns1240.016
    Non-AF patients749nsnsns4810.001181ns1070.021
    AF patients59nsnsns46ns23ns17ns
10-year divisions of age i808nsnsns5270.007204ns1240.021
    Non-AF patients749nsnsns4810.004181ns1070.031
    AF patients59nsnsns46ns23ns17ns

LA, Left Atrium; LAA, Left Atrial Appendage; ns, not significant.

a r = 0.156.

b r = 0.148.

c r = 0.861.

d r = 0.162.

e r = 0.835.

f r = 0.945.

g Age median 53 years; patients over 53 years old compared with younger patients.

h Groups: <48 years (26.3%), 48–53 years (24.3%), 54–58 years (23.8%), ≥59 years (25.6%).

i Groups: <40 years (9.4%), 40–49 years (24.6%), 50–59 years (44.6%), ≥60 years (21.5%).

Fig 4

Relative Left Atrial Appendage (LAA) length and relative Left Atrium (LA) area according to age quartile, with 95% confidence intervals.

BMI, Body Mass Index; LA, Left Atrium; LAA, Left Atrial Appendage; NA, not applicable; ns, not significant; TIA, Transient Ischemic Attack. BMI, Body Mass Index; LA, Left Atrium; LAA, Left Atrial Appendage; NA, not applicable; ns, not significant; TIA, Transient Ischemic Attack. LA, Left Atrium; LAA, Left Atrial Appendage; ns, not significant. a r = 0.156. b r = 0.148. c r = 0.861. d r = 0.162. e r = 0.835. f r = 0.945. g Age median 53 years; patients over 53 years old compared with younger patients. h Groups: <48 years (26.3%), 48–53 years (24.3%), 54–58 years (23.8%), ≥59 years (25.6%). i Groups: <40 years (9.4%), 40–49 years (24.6%), 50–59 years (44.6%), ≥60 years (21.5%). The proportion of LAAs in each morphological class were: 62.3% (WindSock), 18.6% (Cactus), 10.0% (ChickenWing), and 9.2% (CauliFlower). A greater number of LAA morphological classes with multiple lobes (i.e. Cactus and WindSock) were seen in overweight patients vs. patients of a normal weight (84% vs. 76% (p = 0.010)). In addition, gender significantly affected the number of LAA lobes (p = 0.007), with men presenting more frequently with multi-lobed LAAs (46% vs. 35%; p = 0.003). Regarding relative LA area, dyslipidemia (10.4±2.9 cm2/m2 vs. 9.3±2.3 cm2/m2; p = 0.043), a history of AF (11.7±3.2 cm2/m2 vs. 9.5±2.3 cm2/m2; p = 0.004), calcified and/or stenotic coronary arteries (10.4±2.9 cm2/m2 vs. 9.3±2.3 cm2/m2; p = 0.045), myocardial infarction (MI, 13.5±4.0 cm2/m2 vs. 9.6±2.5 cm2/m2; p = 0.015), and moderately severe/severe mitral (14.0±1.1 cm2/m2 vs. 9.8±2.6 cm2/m2; p = 0.045) or aortic regurgitation (15.8±3.1 cm2/m2 vs. 9.6±2.4 cm2/m2; p = 0.008), were all associated with an increased relative LA area. Age, together with the variables shown in Table 2 that correlated with relative LA area were then adjusted in linear regression analyses. With an adjusted R2 value of 0.362, age (p = 0.003), a history of AF (p = 0.021), a history of MI (p<0.001), and moderately severe/severe aortic regurgitation (p<0.001), all correlated with an increased relative LA area. Similarly, the variables shown in Fig 3 that correlated with relative LAA length were also adjusted in linear regression analyses. Age (p<0.001), female gender (p = 0.003), and moderately severe/severe aortic/mitral regurgitation (p = 0.014), all correlated with an increased relative LAA length, with an adjusted R2 value of 0.058.

Patients without atrial fibrillation

Table 3 shows the associations between LAA morphology and diagnosed medical conditions in patients without AF (n = 749). In terms of relative LAA length, the results were comparable to those obtained for the overall population. In addition, as shown in Table 4, age was a significant correlate for a longer relative length of LAA (r = 0.162; p<0.001). Regarding the relative LA area, only age (r = 0.835; p<0.001), a history of MI (13.5±4.0 cm2/m2 vs. 9.3±2.1 cm2/m2; p = 0.009), and moderately severe/severe mitral regurgitation (14.0±1.1 cm2/m2 vs. 9.4±2.4 cm2/m2; p = 0.034), remained significant. LA size was found to correlate with LAA length (r = 0.251; p = 0.001), but not with relative LAA length or any other LAA characteristics. The proportions of LAA morphological classes were: 61.5% (WindSock), 18.8% (Cactus), 10.0% (ChickenWing), and 9.6% (CauliFlower). Men more frequently exhibited multi-lobed LAAs (45% vs. 35%; p = 0.007), with a shorter relative LAA length (2.1±4.8 cm/m2 vs. 2.3±0.47 cm/m2; p<0.001) vs. women. Among those patients with a normal weight, relative LAA length lost its gender-specific association. Similarly, among overweight patients, the multi-lobed status lost its association with gender. The division of morphological classes showed a significant difference (p = 0.003) when comparing patients that were overweight versus those of a normal weight, with overweight patients exhibiting a greater number of multi-lobed LAA morphological subtypes (84% vs. 76%; p = 0.021). Excluding those patients with a history of stroke or TIA did not affect any of the previously described data.

Discussion

We retrospectively assessed LAA morphology in a comprehensive, consecutive study population, deriving correlates for LAA morphology with demographic data, and diagnosed medical conditions. The key findings of our study for the overall population, and non-AF population, were that age and gender influenced relative LAA length, and that men exhibited more multi-lobed LAAs compared to women. Moreover, if the patient was overweight, the multi-lobed LAA form was more prevalent. In contrast to this study, and its largely non-AF patient population, the majority of previous LAA morphological studies have focused on subjects with AF [18-20]. As far as we are aware, this is the most extensive study to explore LAA morphology in a non-AF population. We analyzed a consecutive series of patients undergoing coronary artery CT angiography, which was undertaken to rule out the presence of coronary artery disease in patients with a low pretest probability of this condition. Our study patients can therefore be considered to be an appropriate representation of the normal population. CCTA was performed at the mid-diastolic phase and in sinus rhythm. The LAA volume changes dynamically according to the cardiac cycle, with the greatest volume apparent at the ventricular end-systolic phase [21]. Therefore, our results for LAA length likely represent its intermediate value. However, the LAA is known to exhibit more variability in terms of volume and orifice size during the cardiac cycle in patients with sinus rhythm compared to those with AF [22].

Left atrial appendage morphology

In our study, age, gender, weight, and smoking status all influenced LAA features, with these associations comparable in the overall and non-AF populations. The frequency of embolic events increases with age [23], although relatively few studies have investigated the possible influence of age on LAA morphology. Aging might alter the properties of the LAA wall as well as other components of the cardiovascular system, with this remodeling increasing the risk of thrombosis. These events present one possible explanation for the higher prevalence of embolic events in elderly patients. We could find no association between aging and direct morphological features of the LAA. Veinot et al. and Boucebci et al. both reported similar results regarding LAA length and lobe number in smaller non-AF populations (n = 500 and n = 193, respectively) [13,24], with Ilercil et al. examining LAA volume in AF patients [25]. However, after adjusting LAA lengths by BSA values, a positive correlation was identified between LAA length and age. While the study by Boucebci et al. excluded reports on BSA-related LAA length, BSA indexed to LAA volume was found to display an age-related association, agreeing with our data [24]. Men exhibited more multi-lobed and longer LAAs than women, but after adjusting for BSA values, women were found to exhibit significantly longer LAAs. Therefore, the elevated proportion of smokers among our male patients may explain the shorter relative LAA lengths among smokers compared to non-smokers. Boucebci et al. reported that men had longer LAAs, but that lobe number, or BSA-related LAA volume, presented no significant differences between the genders [24]. Veinot et al. also failed to find any gender-specific effects for LAA length, body-size-related LAA length, or the number of LAA lobes [13]. However different amounts of pericardial fat might account for the discordance between studies. After excluding patients with a normal body mass from our analyses, gender specific differences in LAA lobe number were lost. Furthermore, different study methodologies were used. We analyzed LAAs using a multiplanar reconstruction view whereas Boucebci et al. used three-dimensional reconstructions, and Veinot et al. examined autopsied hearts. The amount of epicardial adipose tissue has been associated with lowered LAA ejection fraction in AF patients which may be attributed to increased numbers of adipocytes and their remodeling effects [26]. We found that overweight patients manifested a greater number of multi-lobed LAA morphological subtypes compared to patients with a normal weight, although there was no association with the actual lobe number. These data suggest that increased pericardial fat in obese subjects leads to a deformation of the LAA wall, thereby remodeling this structure [12]. According to our results, the LAA is significantly longer in patients with severe mitral and/or aortic valve regurgitation vs. patients with no valvular regurgitation. Chronic valvular regurgitation provokes both volume and pressure overload in the left side of the heart [27,28] which may elongate the LAA. Data on mitral or aortic valve stenoses were, unfortunately, unavailable for our patients. The number of patients with significant valve stenosis was very low since mitral stenosis is extremely rare in the Finnish Caucasian population, and CCTA is not included in the preoperative evaluation of patients with aortic stenosis. The AF patients had markedly elongated LAAs, but this difference (between AF and non-AF patients) disappeared after indexing to BSA values. Relatively few studies have investigated LAA length in patients with AF but without a history of stroke. AF patients were found to display larger LAA volumes and greater LAA orifice dimensions, although only in smaller, non-BSA-indexed patient populations (n = 34 and n = 46) [6,29]. In a short-term (2.5 months) follow-up study regarding recent onset AF, non-BSA-indexed LAA length exhibited no significant increase between the measurement dates [30].

Left atrium size

We found that men had a larger LA area than women, and that BSA positively correlated with LA area. These results indicate that increased body mass imposes more pressure on the LA, as reported in an earlier study on male gender and obesity [31,32]. Predictably, the difference between genders disappeared after values for LA area were BSA-indexed, paralleling the results of Maceira et al. [33]. Thereafter, we found that aging, prior MI, and aortic/mitral regurgitation were associated with increased relative LA area in both study groups. Furthermore, AF patients also possessed larger relative LA areas. Age positively correlated with increased relative LA area in the overall study population, in non-AF patients, and in AF patients. These data contradict several earlier studies. Aurigemma et al. found no association between BSA indexed LA volume and healthy aging [34]. In contrast to our study, none of their study patients (n = 230) had been diagnosed with cardiovascular diseases. Other studies have reported that aging correlates with decreased relative LA diameter in healthy patients [33], and similar LA volumes (not BSA indexed) in AF patients [25]. Moreover, larger LA areas are suggested to be a result of an underlying pathological dysfunction rather than healthy aging [35,36]. Several etiological factors can cause enlargement of the LA, i.e. AF, mitral regurgitation, hypertension, and other causes of heart failure [29,36-39]. LA enlargement typically leads to increased pressure on the LAA. In our study, an increased LA size was associated with elongation in both AF and non-AF patients. However, after LAA length indexing to BSA, this correlation disappeared. The relative LA area was significantly larger in patients with severe aortic or mitral valve regurgitation compared to patients with no regurgitation, as suggested previously [27,28]. In addition, a history of MI has been indicated to cause long-term dilation of the left atrium [40], which was also recognized in the present study. Based on our results, we could hypothesize that remodeling of the LAA may be involved in cardioembolic events. First, as the lumen of the LAA is enlarged and reshaped due to fibrotic degeneration or other causes, this process may alter the hemodynamic profile inside LAA predisposing to clot formation even without AF. Second, as these structure walls stretch, electrical conduction of the heart is deteriorated resulting eventually in arrhythmia. The AF may thus follow atrial and LAA enlargement [41,42]. Earlier studies have noted that enlarged LAs [41] and LAAs [43] are prevalent also in non-AF stroke patients. AF might therefore represent one essential but not an exclusive factor in the etiology of cardioembolic events.

Limitations

Our study has limitations. Women were overrepresented in our study population, and our subgroup of AF patients was small compared to the non-AF subgroup, which may have biased comparisons. All patients were imaged during mid-diastole, which is not an optimal phase with which to observe maximal LAA length, although it does optimize morphological imaging. CCTA imaging during the end-systolic phase would have resulted in non-diagnostic coronary images and could therefore not be justified. While only one observer assessed LAA morphological features, intra-observer and inter-observer reproducibility proved to be good in an earlier study [44]. The retrospective assessment of weight status was challenging. In some cases this classification was based on BMI, which was not necessarily registered at the time of CCTA evaluation. Furthermore, it was difficult to make an accurate assessment of the degree of stenosis in calcified coronary arteries using CCTA.

Conclusions

Our study findings among adults suggest the following: aging demonstrates a positive correlation with BSA-related LAA length, the female gender is associated with increased relative LAA length, and that multi-lobed LAAs are more frequent in male patients. Overweight patients may possess more LAA morphological classes with multiple lobes. The relative LAA length and number of LAA lobes seems to be unaffected by a history of AF, or increased LA size. Cardioembolic events may not be exclusively tied to fibrillation, and progressive enlargement and fibrotic degeneration of the LAA may be of clinical importance.
  44 in total

1.  Anatomical remodeling of left atria in subjects with chronic and paroxysmal atrial fibrillation evaluated by multislice computed tomography.

Authors:  Megumi Imada; Nobusada Funabashi; Miki Asano; Masae Uehara; Marehiko Ueda; Issei Komuro
Journal:  Int J Cardiol       Date:  2006-10-24       Impact factor: 4.164

Review 2.  From pressure overload to volume overload: aortic regurgitation after transcatheter aortic valve implantation.

Authors:  Michael Gotzmann; Michael Lindstaedt; Andreas Mügge
Journal:  Am Heart J       Date:  2012-06       Impact factor: 4.749

3.  Left atrial appendage: an underrecognized trigger site of atrial fibrillation.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Sanghamitra Mohanty; Rodney Horton; G Joseph Gallinghouse; Shane M Bailey; Jason D Zagrodzky; Pasquale Santangeli; Steven Hao; Richard Hongo; Salwa Beheiry; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Amin Al-Ahmad; Paul Wang; Jennifer E Cummings; Robert A Schweikert; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

4.  Influence of left atrial pressure on left atrial appendage flow velocity patterns in patients in sinus rhythm.

Authors:  T Tabata; T Oki; N Fukuda; A Iuchi; K Manabe; Y Kageji; M Sasaki; H Yamada; S Ito
Journal:  J Am Soc Echocardiogr       Date:  1996 Nov-Dec       Impact factor: 5.251

5.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.

Authors:  A J Sanfilippo; V M Abascal; M Sheehan; L B Oertel; P Harrigan; R A Hughes; A E Weyman
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

6.  Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation.

Authors:  Masayoshi Yamamoto; Yoshihiro Seo; Naoto Kawamatsu; Kimi Sato; Akinori Sugano; Tomoko Machino-Ohtsuka; Ryo Kawamura; Hideki Nakajima; Miyako Igarashi; Yukio Sekiguchi; Tomoko Ishizu; Kazutaka Aonuma
Journal:  Circ Cardiovasc Imaging       Date:  2014-02-12       Impact factor: 7.792

7.  Left atrial volume overload in mitral regurgitation: a two dimensional echocardiographic study.

Authors:  L G Gehl; G S Mintz; M N Kotler; B L Segal
Journal:  Am J Cardiol       Date:  1982-01       Impact factor: 2.778

Review 8.  Cardiac imaging for assessment of left atrial appendage stasis and thrombosis.

Authors:  Jorge Romero; Jie J Cao; Mario J Garcia; Cynthia C Taub
Journal:  Nat Rev Cardiol       Date:  2014-06-10       Impact factor: 32.419

9.  Left atrial volume and geometry in healthy aging: the Cardiovascular Health Study.

Authors:  Gerard P Aurigemma; John S Gottdiener; Alice M Arnold; Marcello Chinali; Jeffrey C Hill; Dalane Kitzman
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-11       Impact factor: 7.792

10.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

View more
  7 in total

1.  Diagnosis of coronary artery disease in patients with atrial fibrillation using low tube voltage coronary CT angiography with isotonic low-concentration contrast agent.

Authors:  Yuning Pan; Qiuli Huang; Yingchao Zhu; Xinrong Zou; Huimin Chu; Xianfeng Du; Aijing Li; Shizhong Bu
Journal:  Int J Cardiovasc Imaging       Date:  2019-07-30       Impact factor: 2.357

2.  Gross anatomic relationship between the human left atrial appendage and the left ventricular summit region: implications for catheter ablation of ventricular arrhythmias originating from the left ventricular summit.

Authors:  M Kuniewicz; K Budnicka; M Dusza; N Jakob; N Cholewa; R Defonseka; M Gosnell; T Wadhwa; J Walocha; H Dobrzynski; M Hołda
Journal:  J Interv Card Electrophysiol       Date:  2022-03-09       Impact factor: 1.900

Review 3.  Computed tomography measurement for left atrial appendage closure.

Authors:  Masahiko Asami
Journal:  Cardiovasc Interv Ther       Date:  2022-03-20

Review 4.  The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation.

Authors:  Rocco J Cannistraro; James F Meschia
Journal:  Curr Cardiol Rep       Date:  2018-09-12       Impact factor: 2.931

5.  The left atrial appendage morphology and gender differences by multi-detector computed tomography in an Egyptian population.

Authors:  Mohammed Elzeneini; Ahmed Elshazly; Ahmed El Mahmoudy Nayel
Journal:  Egypt Heart J       Date:  2020-07-02

6.  Complex Left Atrial Appendage Morphology Is an Independent Risk Factor for Cryptogenic Ischemic Stroke.

Authors:  Indranill Basu-Ray; Deepthi Sudhakar; Gregory Schwing; Dominique Monlezun; Lucy Zhang; Sumit K Shah; Deep Pujara; Kevin Ting; Nidal Abi Rafeh; Gholam Ali; Mark Cassidy; Kenneth Ellenbogen; Glen Levine; Wilson Lam; Nilesh Mathuria; Mohammad Saeed; Jared Bunch; Sheryl Martin-Schild; Michael Gold; Arash Aryana; Mehdi Razavi; Abdi Rasekh
Journal:  Front Cardiovasc Med       Date:  2018-10-23

7.  Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation.

Authors:  Chaim Yosefy; Marina Pery; Roman Nevzorov; Xavier Piltz; Azriel Osherov; Jamal Jafari; Ronen Beeri; Enrique Gallego-Colon; Aner Daum; Vladimir Khalameizer
Journal:  Clin Cardiol       Date:  2019-11-22       Impact factor: 2.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.